IL151972A0 - Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof - Google Patents

Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof

Info

Publication number
IL151972A0
IL151972A0 IL15197201A IL15197201A IL151972A0 IL 151972 A0 IL151972 A0 IL 151972A0 IL 15197201 A IL15197201 A IL 15197201A IL 15197201 A IL15197201 A IL 15197201A IL 151972 A0 IL151972 A0 IL 151972A0
Authority
IL
Israel
Prior art keywords
pigr
methods
stalk region
secretory component
ligands directed
Prior art date
Application number
IL15197201A
Other languages
English (en)
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of IL151972A0 publication Critical patent/IL151972A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/23—Immunoglobulins specific features characterized by taxonomic origin from birds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C07K2317/622—Single chain antibody (scFv)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77—Internalization into the cell
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15197201A 2000-03-27 2001-03-26 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof IL151972A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19219800P 2000-03-27 2000-03-27
US19219700P 2000-03-27 2000-03-27
PCT/US2001/009699 WO2001072846A2 (en) 2000-03-27 2001-03-26 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof

Publications (1)

Publication Number Publication Date
IL151972A0 true IL151972A0 (en) 2003-04-10

Family

ID=26887830

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15197201A IL151972A0 (en) 2000-03-27 2001-03-26 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof

Country Status (8)

Country Link
US (2) US6855810B2 (xx)
EP (1) EP1268555A2 (xx)
JP (1) JP2003528891A (xx)
AU (1) AU2001252970A1 (xx)
CA (1) CA2404756A1 (xx)
IL (1) IL151972A0 (xx)
MX (1) MXPA02009449A (xx)
WO (1) WO2001072846A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02011093A (es) 2000-05-10 2004-08-19 David A Sirbasku Composiciones y metodos para el diagnostico, tratamiento y prevencion de canceres que responden a la hormona esteroidea.
US20030166160A1 (en) * 2001-09-06 2003-09-04 Hawley Stephen B. Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands
MXPA03002918A (es) * 2000-10-02 2004-04-20 Arizeke Pharmaceuticals Inc Composiciones y metodos para el transporte de agentes biologicamente activos a traves de barreras celulares.
EP1490502B1 (en) * 2001-11-14 2013-01-09 Signe BioPharma Inc. Screening method for predicting susceptibility to breast cancer
WO2004062603A2 (en) * 2003-01-09 2004-07-29 Arizeke Pharmaceuticals Inc. Methods of treating lung diseases
AU2004204763A1 (en) * 2003-01-09 2004-07-29 Arizeke Pharmaceuticals Inc. Compositions and methods for targeted biological delivery of molecular carriers
EP2322622A3 (en) * 2005-03-25 2012-03-07 National Research Council of Canada Method for isolation of soluble polypeptides
KR100958198B1 (ko) * 2008-06-18 2010-05-14 고려대학교 산학협력단 실시간 연속 검출장치
US20130072783A1 (en) 2011-09-16 2013-03-21 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Indicating proximity of a body-insertable device to a destination region of interest
EP4007607A4 (en) * 2019-08-02 2024-01-10 Janssen Biotech Inc MATERIALS AND METHODS FOR TARGETING POLYMERIC ANTIBODY RECEPTORS
WO2022081460A1 (en) * 2020-10-12 2022-04-21 Janssen Biotech, Inc. Biosynthetic materials and methods for multidirectional biotransportation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0752005B1 (en) * 1994-03-23 2008-10-08 Ohio University Compacted nucleic acids and their delivery to cells
CA2208783C (en) * 1994-12-30 2010-09-28 Planet Biotechnology, Inc. Methods for producing immunoglobulins containing protection proteins in plants and their use
US6046037A (en) * 1994-12-30 2000-04-04 Hiatt; Andrew C. Method for producing immunoglobulins containing protection proteins in plants and their use
AU728587B2 (en) * 1996-06-04 2001-01-11 Regents Of The University Of California, The Cellular internalization of pIgR stalk and associated ligands
US6251392B1 (en) * 1997-10-20 2001-06-26 Epicyte Pharmaceuticals, Inc. Epithelial cell targeting agent

Also Published As

Publication number Publication date
US20050201932A1 (en) 2005-09-15
CA2404756A1 (en) 2001-10-04
JP2003528891A (ja) 2003-09-30
MXPA02009449A (es) 2003-09-22
US6855810B2 (en) 2005-02-15
AU2001252970A1 (en) 2001-10-08
WO2001072846A2 (en) 2001-10-04
EP1268555A2 (en) 2003-01-02
US20020102657A1 (en) 2002-08-01
WO2001072846A3 (en) 2002-04-04
US7404954B2 (en) 2008-07-29

Similar Documents

Publication Publication Date Title
IL154272A0 (en) The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands
ZA200205071B (en) Substrates carrying polymers of linked sandwich coordination compounds and methods of use thereof.
HK1091132A1 (en) Anti-cd33 antibodies and the use thereof -cd33
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
IL144578A0 (en) Antibodies specific to kdr and uses thereof
IL168058A0 (en) Antibodies that bind celi-associated ca 125/0722p and methods of use thereof
IL157142A0 (en) Modified antibodies and methods of use
IL152116A0 (en) Prion-binding ligands and methods of using same
HUP0302376A3 (en) Anti-tnf antibodies, compositions, methods and uses
IL154325A0 (en) Anti-il-12 antibodies, compositions, methods and uses
IL166244A0 (en) Super humanized antibodies
PL375064A1 (en) Treatment of renal carcinoma using antibodies against the egfr
EP1347980A4 (en) RECEPTOR SPECIFIC COMPOUNDS OF ADENOSINE-A1, -A2A, AND-A3 AND USES THEREOF
AU8192001A (en) Catalyst and process for the preparation of hydrocarbons
AU2002340167A8 (en) Anti-hla-dr antibodies and the methods of using thereof
AU2003253910A8 (en) Methods for the regeneration and transformation of cotton
EP1482985A4 (en) TECHNETIUM-DIPYRIDINE COMPLEXES AND METHODS OF USE THEREOF
GB2361223B (en) Climbing appliance for roping-up and roping-down operations
EP1254140A4 (en) SAFRAMYCIN-ECTEINASCIDIN SERIES COMPOUNDS, USES AND SYNTHESIS
IL151972A0 (en) Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
AU2608602A (en) Silensed anti-cd28 antibodies and use thereof
MXPA02001797A (es) BANDA DE SUJECION DE TIPO DE EXPANSION CARACTERIZADA POR UN DISEnO SIMPLIFICADO Y FACILIDAD DE USO.
EP1483233A4 (en) SUBSTITUTED TETRAHYDROISOQUINOLEINE COMPOUNDS, METHODS OF PREPARATION AND USE THEREOF
EP1418194A4 (en) MODIFIED POLYALKYLENEIMINE AND METHODS OF USE
EP1517879A4 (en) AMINOALKYLPHENOLS AND METHODS OF USE AND MANUFACTURE